Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK damns breast implant rule

This article was originally published in Clinica

Executive Summary

"The current regulatory system is deeply flawed." This is the main conclusion to emerge from the UK House of Commons health committee enquiry on the regulation of breast implantation and the provision by the government of information regarding its safety. While praising the Department of Health (DoH) and the Medical Devices Agency (MDA) for "their efforts to have breast implants reclassified as high risk devices and to achieve uniform standards in Europe's notified bodies", it finds that the system "may need an even more radical overhaul".





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts